FDA Hopes to Publish List of Cross-Platform Standard Microarray Probes Later This Summer | GenomeWeb

The US Food and Drug Administration plans to issue a preliminary list of genes that are common to the three leading microarray platforms — Affymetrix’s GeneChips, Agilent Technologies’ microarrays, and Amersham’s CodeLink — some time this summer, Karol Thompson of the FDA told BioArray News this week.

Last week, Gene Logic of Gaithersburg, Md., delivered a CD-ROM to the FDA Center for Drug Evaluation and Research containing data derived from the company’s library of gene-expression studies of rat liver — a collaborative project initiated in August.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.